On Nov 19, the latest report “Global ADC Drug CDMO Service Market 2025 by Manufacturers, Regions, Types and Applications, Forecast to 2031” from Global Info Research provides a detailed and comprehensive analysis of the global ADC Drug CDMO Service market. The report provides both quantitative and qualitative analysis by manufacturers, regions and countries, types and applications. As the market is constantly changing, this report explores market competition, supply and demand trends, and key factors that are causing many market demand changes. The report also provides company profiles and product examples of some of the competitors, as well as market share estimates for some of the leading players in 2025.
Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/2638725/adc-drug-cdmo-service
According to our latest research, the global ADC Drug CDMO Service market size will reach USD 9685 million in 2031, growing at a CAGR of 18.6% over the analysis period.
ADC drugs, also known as antibody drug coupling agents, work by coupling small molecule drugs with antibodies through linkers to form drugs. These drugs combine the high targeting ability of antibodies with the strong killing power of chemical drugs, and are considered the most promising next-generation antibody technology. To reduce research and development costs, most ADC drug development worldwide chooses outsourcing, leveraging CDMO companies to enter clinical and market more quickly. CDMO services refer to pharmaceutical and biotechnology companies outsourcing the research and production of their drugs or biological products to professional CDMO companies. These CDMO companies provide a range of services, including but not limited to drug synthesis, chemical and biological analysis, formulation development, clinical production, and commercial production. The core of CDMO services lies in its ability to customize and specialize, which can meet the specific needs of different customers at different stages.
One of the primary drivers of the ADC drug CDMO market is the increasing demand for targeted therapies, particularly in oncology. Cancer remains a leading cause of death globally, and the traditional methods of chemotherapy, while effective, often come with severe side effects that limit their use. ADCs, which combine the targeting ability of monoclonal antibodies with the potency of cytotoxic drugs, offer a more precise and effective treatment option. By delivering the toxic drug directly to cancer cells, ADCs minimize damage to healthy tissues, thereby reducing adverse effects.
The demand for ADCs is expected to increase significantly due to their ability to treat a wide range of cancers, including breast cancer, leukemia, and lung cancer. As the pipeline for ADC drugs continues to expand, pharmaceutical companies are increasingly relying on CDMOs to support the development and manufacturing of these complex therapies.
This report is a detailed and comprehensive analysis for global ADC Drug CDMO Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
ADC Drug CDMO Service market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type: Cleavable Linkers、 Non-cleavable Linkers
Market segment by Application: Small and Medium-sized Pharmaceutical Companies、 Large Pharmaceutical Companies
Major players covered: Lonza Group、 Merck KGaA、 WuXi XDC、 Abbvie、 Piramal Pharma Solutions、 Catalent、 Sterling Pharma Solutions、 Axplora、 Aji Bio-Pharma、 BSP Pharmaceuticals、 Cerbios-Pharma、 Goodwin Biotechnology、 TOT Biopharm、 Huadong Medicine、 Innovent Biologics、 Shanghai Henlius Biotech
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe ADC Drug CDMO Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of ADC Drug CDMO Service, with price, sales quantity, revenue, and global market share of ADC Drug CDMO Service from 2020 to 2025.
Chapter 3, the ADC Drug CDMO Service competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the ADC Drug CDMO Service breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment ADC Drug CDMO Service the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the ADC Drug CDMO Service sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2024.and ADC Drug CDMO Service market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of ADC Drug CDMO Service.
Chapter 14 and 15, to describe ADC Drug CDMO Service sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for ADC Drug CDMO Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
